Metabolomics is fast becoming a promising leading field in the practice of precision medicine. The close association between metabolites and phenotype can provide physicians and researchers a powerful tool to obtain valuable, real-time information on the pathophysiological condition of an individual. Among other promising fields of study, metabolomics has proven useful to enable precise advancements in disease identification, characterization of disturbances, exploration of therapeutic targets, and discovery of biomarkers for diagnosis and treatment monitoring.

Within metabolomics, lipidomics is a crucial field for identifying disease-specific biomarkers and monitoring drug therapies. Through its focus on the diverse roles of lipids, lipidomics plays a pivotal role in disease diagnosis and prognosis.

In the world of metabolomics, it’s not just about having the right tools; it’s also about working with the right research allies. OWL Metabolomics stands as a leading force in the metabolomics and lipidomics fields, delivering high-potential advantages to get metabolic insights that drive success to your research.

Three keys to our success are encapsulated in our state-of-the-art analytical platforms, our expert team, and our unwavering commitment to deliver more than the basics.

OWL Metabolomics has optimized complete and highly productive metabolomic platforms. Our services include specific UHPLC-MS analytical platforms, tailored to your unique experimental needs and design.

The strength of OWL Metabolomics lies in our multidisciplinary Scientific Team. With a fusion of scientific expertise, open communication and trust, our team creates enduring connections. We offer scientific guidance from experts in the field, and effective counsel for optimal experimental design from sample collection to statistical discussion.